35490-07-4

Usage

Uses

Used in Pharmaceutical Industry:
2-Cyclohexene-1-carboxylic acid, 2-methyl-4-oxo-, methyl ester is used as an intermediate in the synthesis of various pharmaceutical compounds due to its unique chemical structure and reactivity.
Used in Food Industry:
In the food industry, 2-Cyclohexene-1-carboxylic acid, 2-methyl-4-oxo-, methyl ester is used as a flavoring agent to impart a fruity aroma and taste to food products.
Used in Fragrance and Perfume Production:
2-Cyclohexene-1-carboxylic acid, 2-methyl-4-oxo-, methyl ester is used as a key ingredient in the production of fragrances and perfumes, providing a distinct and pleasant scent.
Safety Precautions:
It is important to handle and store 2-Cyclohexene-1-carboxylic acid, 2-methyl-4-oxo-, methyl ester with care, as it can be harmful if ingested, inhaled, or comes into contact with the skin or eyes. Proper safety measures should be taken during its use in various applications.

Upstream product

• 105-45-3 acetoacetic acid methyl ester 
• 35490-04-1 2-acetyl-5-oxo-hexanoic acid methyl ester 
• 67257-30-1 diethyl 2-oxo-3-butenylphosphonate 
• 220283-98-7 4-methyl-6-oxo-cyclohex-4-ene-1,3-dicarboxylic acid dimethyl ester 
• 78-94-4 methyl vinyl ketone 
• 50-00-0 formaldehyd 

Downstream Products

• 220283-99-8 3-but-3-enyl-2-methyl-4-oxo-cyclohex-2-enecarboxylic acid methyl ester 
• 620167-67-1 3-(4-benzyloxy-2-bromo-3-methoxy-benzyl)-2-methyl-4-oxo-cyclohex-2-enecarboxylic acid methyl ester 
• 849097-82-1 3-(2-bromo-4-methoxy-benzyl)-2-methyl-4-oxo-cyclohex-2-enecarboxylic acid methyl ester 
• 849097-95-6 3-(2-bromo-3,4-dimethoxy-benzyl)-2-methyl-4-oxo-cyclohex-2-enecarboxylic acid methyl ester 
• 849097-97-8 2-(2-bromo-3,4-dimethoxy-benzyl)-3,3-dimethyl-cyclohexanone 
• 849097-96-7 2-(2-bromo-3,4-dimethoxy-benzyl)-3-methyl-cyclohex-2-enone 
• 155855-26-8 2-(4-Methoxy-2-bromobenzyl)-3,3-dimethylcyclohexan-1-one 
• 155855-22-4 2-(4-Methoxy-2-bromobenzyl)-3-methylcyclohex-2-en-1-one 
• 620167-53-5 2-(4-benzyloxy-2-bromo-3-methoxy-benzyl)-3,3-dimethyl-cyclohexanone 
• 620167-52-4 2-(4-benzyloxy-2-bromo-3-methoxy-benzyl)-3-methyl-4-oxo-cyclohex-2-enone 
• 7195-71-3 3-(2-methyl-6-oxo-cyclohex-1-enyl)-propionic acid 
• 1072098-04-4 4-allyloxy-2-methyl-3-phenylaminobenzoic acid methyl ester 
• 57556-31-7 4-hydroxy-2-methylbenzoic acid methyl ester 
• 740799-82-0 3,4-dihydroxy-2-methyl benzoic acid methyl ester 

Relevant academic research and scientific papers

SYNTHESIS OF 20-NOR-SALVINORIN A

The invention provides 20-nor-salvinorin A, an analog of the kappa-opioid agonist salvinorin A. The 20-nor-salvinorin A is an active kappa-opioid modulator and can be used for treatment of medical conditions wherein modulation of the kappa-opioid receptor

A highly efficient metal-free approach to: Meta - And multiple-substituted phenols via a simple oxidation of cyclohexenones

A novel and efficient metal-free approach to substituted phenols has been disclosed from simple and readily available cyclohexenones and cyclohexenone equivalents. Dimethyl sulfoxide (DMSO), a simple and common organic reagent, was employed as a mild oxidant in this I2-catalysis, which significantly tolerates various substituents including some easily oxidizable or reducible functionalities. The challenging meta- and multiple-substituted phenols could be well prepared by this method. The metal-free and mild oxidation make this protocol very simple, practical, and easy to handle.

THIAZOLE-SUBSTITUTED AMINOHETEROARYLS AS SPLEEN TYROSINE KINASE INHIBITORS

The invention provides certain thiazole-substituted aminoheteroaryl compounds of the Formula (I) (I), or pharmaceutically acceptable salts thereof, wherein ring R1, R2, R3, R4, ring A, and the subscripts n1, n2, and r are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).

THIAZOLE-SUBSTITUTED AMINOHETEROARYLS AS SPLEEN TYROSINE KINASE INHIBITORS

The invention provides certain thiazole-substituted aminoheteroaryl compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein ring R1, R2, R3, R4, ring B, and the subscript r are as defi

THIAZOLE-SUBSTITUTED AMINOHETEROARYLS AS SPLEEN TYROSINE KINASE INHIBITORS

The invention provides certain thiazole-substituted aminoheteroaryl compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R3, R5, R6, A, Cy and the subscripts r, s, and t are as

TRIAZOLYL DERIVATIVES AS SYK INHIBITORS

Provided are triazole derivatives of Formula I which are potent inhibitors of spleen tyrosine kinase and pharmaceutical composition. The triazole derivatives are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.

THIAZOLE-SUBSTITUTED AMINOPYRIMIDINES AS SPLEEN TYROSINE KINASE INHIBITORS

The invention provides certain thiazole-substituted aminopyrimidine compounds of the Formula (I) (I), or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R5, R6, and the subscripts r, s, and t are as defined herein. The invention also provid

THIAZOLE-SUBSTITUTED AMINOHETEROARYLS AS SPLEEN TYROSINE KINASE INHIBITORS

The invention provides certain thiazole-substituted aminoheteroaryl compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein X1, X2, X3, X4, Y1, Y2, Y3, Y4, and R4 are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).

BIPYRIDYLAMINOPYRIDINES AS SYK INHIBITORS

The present invention provides novel pyrimidine amines of formula I which are potent inhibitors of spleen tyrosine kinase, or are prodrugs thereof, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD and rheumatoid arthritis and cancer.

Diaxial diureido decalins as compact, efficient, and tunable anion transporters

Decalins bearing two axial -NHCONHAr substituents and an ester-linked alkyl side chain have been synthesized and studied as anion receptors and transporters. The design relates to steroid-based cholapods but is more compact and less intrinsically lipophil